Opaleye Management Inc. Stoke Therapeutics, Inc. Call Options Transaction History
Opaleye Management Inc.
- $418 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STOK
# of Institutions
139Shares Held
57.6MCall Options Held
2.7KPut Options Held
57.4K-
Black Rock Inc. New York, NY5.41MShares$119 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR5.4MShares$119 Million18.16% of portfolio
-
Rtw Investments, LP New York, NY5.12MShares$113 Million0.89% of portfolio
-
Baker Bros. Advisors LP New York, NY4.63MShares$102 Million0.53% of portfolio
-
Redmile Group, LLC San Francisco, CA4.38MShares$96.2 Million6.04% of portfolio
About Stoke Therapeutics, Inc.
- Ticker STOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,419,300
- Market Cap $867M
- Description
- Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...